Poseida - PSTX Price Chart

Poseida Therapeutics (PSTX) specializes in developing innovative oncology treatments through genetic modification. This asset value chart reflects a trend where the current figure is 9.54. The company's success relies on the safety of DNA editing and the absence of side effects. Meanwhile, R&D centers are operating at full capacity, while vector production is outsourced to certified third-party contractors.

poseida.com - PSTX Price (period 07/04/2022 - 01/18/2025)

Summary analytical data breakdowns for Poseida Therapeutics Inc (PSTX)

- stock value and consensus price forecast:

Price Chart Poseida Therapeutics|PSTX - Forecast Levels Chart

- issuer market value details:

Market Value Poseida Therapeutics Inc|PSTX - Company Buyout Price

- balance sheet equity data:

Accounting Value per Share Poseida Therapeutics|PSTX - Total Net Assets|Market Cap to Net Assets Ratio poseida.com|PSTX - Total Business Assets

- debt and liquidity details:

- financial results and valuation multiples details:

PSTX - Company Net Income|Expected Profit Poseida Therapeutics|PSTX - Market Cap to Earnings|Forward P/E Multiple Poseida Therapeutics, Inc.|PSTX - Price to Net Income Growth Ratio|Enterprise Value to EBITDA Ratio Poseida Therapeutics Inc|PSTX - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Poseida Therapeutics|PSTX - Earnings per share for the trailing year|Quarterly EPS earnings growth poseida.com|PSTX - Net earnings per share growth this year|Earnings growth forecast for next year Poseida Therapeutics

- company sales and revenue statistics:

PSTX - Company Total Revenue|Company Projected Revenue Poseida Therapeutics|PSTX - Price-to-Revenue Ratio|Price-to-Projected Revenue Ratio Poseida Therapeutics Inc

Summary company analytics:Poseida Therapeutics

The selection of defensive assets is based on identifying companies with a unique technological advantage, as evidenced by Poseida Therapeutics (PSTX) creating an innovative non-viral genome editing system for affordable cancer therapy. The current market value of the stock reflects aggregate investor demand for these developments, while the asset's price action on the exchange allows for an assessment of the trend's sustainability and the formation of justified price expectations for the year.

Competitors of Poseida Therapeutics